NovAccess Global Inc. (OTCMKTS:XSNX) Short Interest Down 97.7% in October

NovAccess Global Inc. (OTCMKTS:XSNX) saw a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 400 shares, a decline of 97.7% from the October 15th total of 17,300 shares. Based on an average daily trading volume, of 7,000 shares, the short-interest ratio is presently 0.1 days.

NovAccess Global Price Performance

Shares of OTCMKTS:XSNX opened at $0.01 on Tuesday. NovAccess Global has a 12 month low of $0.00 and a 12 month high of $0.05. The business has a 50-day moving average of $0.01 and a two-hundred day moving average of $0.01. The firm has a market capitalization of $370,204.90, a PE ratio of -0.08 and a beta of 1.89.

NovAccess Global Company Profile

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.